Secondary bipolar disorder and diogenes syndrome in frontotemporal dementia: Behavioral improvement with quetiapine and sodium valproate

Journal of Clinical Psychopharmacology

Volumn 27, Issue 6, 2007, Pages 722-723

  Gálvez Andres, Ana ^a   Blasco Fontecilla, Hilario ^a   González Parra, Silvia ^a   Molina, Juan De Dios ^a   Padín, José Manuel ^b   Rodriguez, Rosalía Hillers ^b  

^a Hospital Dr Rodríguez Lafora   (Spain)

^b San Blas Mental Health Center   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; OLANZAPINE; QUETIAPINE; VALPROMIDE; VENLAFAXINE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; ANHEDONIA; ANXIETY; APATHY; BIPOLAR DISORDER; CASE REPORT; DIOGENES SYNDROME; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HYPOCHONDRIASIS; INSOMNIA; KLUVER BUCY SYNDROME; LETTER; MENTAL INSTABILITY; MINI MENTAL STATE EXAMINATION; PERSONALITY DISORDER; PRIORITY JOURNAL; BEHAVIOR; DEMENTIA; MENTAL HEALTH; MIDDLE AGED; SYNDROME; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BEHAVIORAL SYMPTOMS; BIPOLAR DISORDER; DEMENTIA; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MENTAL STATUS SCHEDULE; MIDDLE AGED; SYNDROME; TREATMENT OUTCOME; VALPROIC ACID;

EID: 39649112917     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31815a57c1     Document Type: Letter

References (19)

1. Mendez MF, Perryman KM. Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria review. J Neuropsychiatry Clin Neurosci. 2002;14:424-429.
2. Mendez MF, Selwood A, Mastri AR, et al. Picks disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology. 1993;43:289-292.
3. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration from AD. Neurology. 2002;58:1608-1615.
4. Gregory CA, Serra-Mestres J, Hodges JR. Early diagnosis of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests? Neuropsychiatry Neuropshychol Behav Neurol. 1999;12:128-135.
5. Beauchet O, Imler D, Cadet L, et al. Diogenes syndrome in the elderly: clinical form or frontal dysfunction? Report of 4 cases. Rev Med Interne. 2002;23(2):122-131.
6. Huey ED, Putnam KT, Grafman J. A systematic review of neurotransmitter deficits and treatments of frontotemporal dementia. Neurology. 2006;66(1):17-22.
7. Moretti R, Torre P, Antonello RM, et al. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. Eur Neurol. 2003;49:13-19.
8. Curtis RC, Resch DS. Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. J Clin Psychopharmacol. 2000;20(3):384-385.
9. Hallyday G, Banerjee S, Philpot M, et al. Community study of people who live in squalor. Lancet. 2002;355(9207):882-886.
10. Cooney C, Hamid W. Review: Diógenes syndrome. Age Aging. 1995;24:451-453.
11. Rosenthal M, Stelian J, Wagner J, et al. Diógenes syndrome and hoarding in the elderly: case reports. Isr J Psychiatry Relat Sci. 1999;36:29-34.
12. Mendez MF. Mania in neurologic disorders. Curr Psychiatry Rep. 2000;2:440-445.
13. Gafoor R, O'Keane V. Three case reports of secondary mania: evidence supporting a right frontotemporal locus. Eur Psychiatry. 2003;18:32-33.
14. Clark L. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry. 2001;158:1605-1611.
15. Perry RJ, Miller BL. Behavior and treatment in frontotemporal dementia. Neurology. 2001;56(11 suppl 4):S46-S51.
16. Yatham LN, Goldstein JM, Vieta E, et al. Atypical antipsychotics in bipolar depression: potential mechanisms of action. J Clin Psychiatry. 2005;(66 suppl 5):40-48.
17. Blasco-Fontecilla H, Bragado Jimenez MD, Garcia Santos LM, et al. Delusional disorder with delusions of parasitosis and jealousy after stroke: treatment with quetiapine and sertraline. J Clin Psychopharmacol. 2005;25(6):615-617.
18. Lakshmi NY, Goldstein JM, Vieta E, et al. Atypical antipsychotics in bipolar depression: potential mechanisms of action. J Clin Psychiatry. 2005;66(5):40-48.
19. Ichikawa J, Young-Chul Ch, Dai J, et al. Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release. Brain Res. 2005;1052:56-62.